Low-Molecular-Weight Heparin Versus Standard Pregnancy Care for Women with Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An Open-Label, Phase III Randomized Controlled Trial

Low-Molecular-Weight Heparin Versus Standard Pregnancy Care for Women with Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An Open-Label, Phase III Randomized Controlled Trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-12, Vol.140 (Supplement 2), p.LBA-5-LBA-5
Hauptverfasser: Quenby, Siobhan, Booth, Katie, Hiller, Louise, Coomarasamy, Arri, Hamulyák, Eva, Scheres, Luuk, de Jong, Paulien G., van Haaps, Thijs, Ewington, Lauren J., Tewary, Shreeya, Goddijn, Mariëtte, Middeldorp, Saskia
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page LBA-5
container_issue Supplement 2
container_start_page LBA-5
container_title Blood
container_volume 140
creator Quenby, Siobhan
Booth, Katie
Hiller, Louise
Coomarasamy, Arri
Hamulyák, Eva
Scheres, Luuk
de Jong, Paulien G.
van Haaps, Thijs
Ewington, Lauren J.
Tewary, Shreeya
Goddijn, Mariëtte
Middeldorp, Saskia
description
doi_str_mv 10.1182/blood-2022-171707
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_171707</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122080909</els_id><sourcerecordid>S0006497122080909</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1857-92b17b2a3e517c407efaca124746ed9780f8b2aa5daa81b103a0d155dede13d03</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhiMEEkvpA3CbI0gYbCeps3BarVoaKVWr0tJjNLEnG6OsvRqnrcqr8XJk2Z57msPo-_Try7IPSn5RqtJfuzFGJ7TUWiijjDSvsoUqdSWk1PJ1tpBSnohiadTb7F1Kv6VURa7LRfa3iY_iIo5k70dkcUd-M0xwTjtkH-AXcbpP8HPC4JAdXDFtAgb7BGtkgj4y3MUtBXj00wDXs4SZwgQXPllk9rghmFGow0DsJ3JwM3DcdnE3-NEjfFw19dmp_vQNVgEudxREgx2Nn-FqwERQ1zVcz3zc-j8zu45h4jiOe83sHt9nb3ocEx0_36Ps9uz0Zn0umssf9XrVCKuq0oil7pTpNOZUKmMLaahHi0oXpjghtzSV7Kv5jaVDrFSnZI7SqbJ05EjlTuZHmTp4LceUmPp2x36L_NQq2e7rt__rt_v67aH-zHw_MDQPe_DEbbKegiXnmezUuuhfoP8BSLePbQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Low-Molecular-Weight Heparin Versus Standard Pregnancy Care for Women with Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An Open-Label, Phase III Randomized Controlled Trial</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Quenby, Siobhan ; Booth, Katie ; Hiller, Louise ; Coomarasamy, Arri ; Hamulyák, Eva ; Scheres, Luuk ; de Jong, Paulien G. ; van Haaps, Thijs ; Ewington, Lauren J. ; Tewary, Shreeya ; Goddijn, Mariëtte ; Middeldorp, Saskia</creator><creatorcontrib>Quenby, Siobhan ; Booth, Katie ; Hiller, Louise ; Coomarasamy, Arri ; Hamulyák, Eva ; Scheres, Luuk ; de Jong, Paulien G. ; van Haaps, Thijs ; Ewington, Lauren J. ; Tewary, Shreeya ; Goddijn, Mariëtte ; Middeldorp, Saskia</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-171707</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-12, Vol.140 (Supplement 2), p.LBA-5-LBA-5</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1857-92b17b2a3e517c407efaca124746ed9780f8b2aa5daa81b103a0d155dede13d03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Quenby, Siobhan</creatorcontrib><creatorcontrib>Booth, Katie</creatorcontrib><creatorcontrib>Hiller, Louise</creatorcontrib><creatorcontrib>Coomarasamy, Arri</creatorcontrib><creatorcontrib>Hamulyák, Eva</creatorcontrib><creatorcontrib>Scheres, Luuk</creatorcontrib><creatorcontrib>de Jong, Paulien G.</creatorcontrib><creatorcontrib>van Haaps, Thijs</creatorcontrib><creatorcontrib>Ewington, Lauren J.</creatorcontrib><creatorcontrib>Tewary, Shreeya</creatorcontrib><creatorcontrib>Goddijn, Mariëtte</creatorcontrib><creatorcontrib>Middeldorp, Saskia</creatorcontrib><title>Low-Molecular-Weight Heparin Versus Standard Pregnancy Care for Women with Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An Open-Label, Phase III Randomized Controlled Trial</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kMFu1DAQhiMEEkvpA3CbI0gYbCeps3BarVoaKVWr0tJjNLEnG6OsvRqnrcqr8XJk2Z57msPo-_Try7IPSn5RqtJfuzFGJ7TUWiijjDSvsoUqdSWk1PJ1tpBSnohiadTb7F1Kv6VURa7LRfa3iY_iIo5k70dkcUd-M0xwTjtkH-AXcbpP8HPC4JAdXDFtAgb7BGtkgj4y3MUtBXj00wDXs4SZwgQXPllk9rghmFGow0DsJ3JwM3DcdnE3-NEjfFw19dmp_vQNVgEudxREgx2Nn-FqwERQ1zVcz3zc-j8zu45h4jiOe83sHt9nb3ocEx0_36Ps9uz0Zn0umssf9XrVCKuq0oil7pTpNOZUKmMLaahHi0oXpjghtzSV7Kv5jaVDrFSnZI7SqbJ05EjlTuZHmTp4LceUmPp2x36L_NQq2e7rt__rt_v67aH-zHw_MDQPe_DEbbKegiXnmezUuuhfoP8BSLePbQ</recordid><startdate>20221206</startdate><enddate>20221206</enddate><creator>Quenby, Siobhan</creator><creator>Booth, Katie</creator><creator>Hiller, Louise</creator><creator>Coomarasamy, Arri</creator><creator>Hamulyák, Eva</creator><creator>Scheres, Luuk</creator><creator>de Jong, Paulien G.</creator><creator>van Haaps, Thijs</creator><creator>Ewington, Lauren J.</creator><creator>Tewary, Shreeya</creator><creator>Goddijn, Mariëtte</creator><creator>Middeldorp, Saskia</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221206</creationdate><title>Low-Molecular-Weight Heparin Versus Standard Pregnancy Care for Women with Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An Open-Label, Phase III Randomized Controlled Trial</title><author>Quenby, Siobhan ; Booth, Katie ; Hiller, Louise ; Coomarasamy, Arri ; Hamulyák, Eva ; Scheres, Luuk ; de Jong, Paulien G. ; van Haaps, Thijs ; Ewington, Lauren J. ; Tewary, Shreeya ; Goddijn, Mariëtte ; Middeldorp, Saskia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1857-92b17b2a3e517c407efaca124746ed9780f8b2aa5daa81b103a0d155dede13d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quenby, Siobhan</creatorcontrib><creatorcontrib>Booth, Katie</creatorcontrib><creatorcontrib>Hiller, Louise</creatorcontrib><creatorcontrib>Coomarasamy, Arri</creatorcontrib><creatorcontrib>Hamulyák, Eva</creatorcontrib><creatorcontrib>Scheres, Luuk</creatorcontrib><creatorcontrib>de Jong, Paulien G.</creatorcontrib><creatorcontrib>van Haaps, Thijs</creatorcontrib><creatorcontrib>Ewington, Lauren J.</creatorcontrib><creatorcontrib>Tewary, Shreeya</creatorcontrib><creatorcontrib>Goddijn, Mariëtte</creatorcontrib><creatorcontrib>Middeldorp, Saskia</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quenby, Siobhan</au><au>Booth, Katie</au><au>Hiller, Louise</au><au>Coomarasamy, Arri</au><au>Hamulyák, Eva</au><au>Scheres, Luuk</au><au>de Jong, Paulien G.</au><au>van Haaps, Thijs</au><au>Ewington, Lauren J.</au><au>Tewary, Shreeya</au><au>Goddijn, Mariëtte</au><au>Middeldorp, Saskia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low-Molecular-Weight Heparin Versus Standard Pregnancy Care for Women with Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An Open-Label, Phase III Randomized Controlled Trial</atitle><jtitle>Blood</jtitle><date>2022-12-06</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 2</issue><spage>LBA-5</spage><epage>LBA-5</epage><pages>LBA-5-LBA-5</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-171707</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-12, Vol.140 (Supplement 2), p.LBA-5-LBA-5
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_171707
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title Low-Molecular-Weight Heparin Versus Standard Pregnancy Care for Women with Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An Open-Label, Phase III Randomized Controlled Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T16%3A03%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low-Molecular-Weight%20Heparin%20Versus%20Standard%20Pregnancy%20Care%20for%20Women%20with%20Recurrent%20Miscarriage%20and%20Inherited%20Thrombophilia%20(ALIFE2):%20An%20Open-Label,%20Phase%20III%20Randomized%20Controlled%20Trial&rft.jtitle=Blood&rft.au=Quenby,%20Siobhan&rft.date=2022-12-06&rft.volume=140&rft.issue=Supplement%202&rft.spage=LBA-5&rft.epage=LBA-5&rft.pages=LBA-5-LBA-5&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-171707&rft_dat=%3Celsevier_cross%3ES0006497122080909%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122080909&rfr_iscdi=true